                         SEQUENCE LISTING

<110>  Centre Lon Brard
       Hospices Civils de Lyon
       Centre Naional de la Recherche Scientifique (CNRS)
       Universit Claude Bernard Lyon 1

 
<120>  Screening methods for identifying compounds which interfere
       with COUP-TFII (NR2F2) or COUP-TFI (NR2F1)


<130>  D30632

<150>  EP 12305558.4
<151>  2012-05-22

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  414
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ala Met Val Val Ser Thr Trp Arg Asp Pro Gln Asp Glu Val Pro 
1               5                   10                  15      


Gly Ser Gln Gly Ser Gln Ala Ser Gln Ala Pro Pro Val Pro Gly Pro 
            20                  25                  30          


Pro Pro Gly Ala Pro His Thr Pro Gln Thr Pro Gly Gln Gly Gly Pro 
        35                  40                  45              


Ala Ser Thr Pro Ala Gln Thr Ala Ala Gly Gly Gln Gly Gly Pro Gly 
    50                  55                  60                  


Gly Pro Gly Ser Asp Lys Gln Gln Gln Gln Gln His Ile Glu Cys Val 
65                  70                  75                  80  


Val Cys Gly Asp Lys Ser Ser Gly Lys His Tyr Gly Gln Phe Thr Cys 
                85                  90                  95      


Glu Gly Cys Lys Ser Phe Phe Lys Arg Ser Val Arg Arg Asn Leu Ser 
            100                 105                 110         


Tyr Thr Cys Arg Ala Asn Arg Asn Cys Pro Ile Asp Gln His His Arg 
        115                 120                 125             


Asn Gln Cys Gln Tyr Cys Arg Leu Lys Lys Cys Leu Lys Val Gly Met 
    130                 135                 140                 


Arg Arg Glu Ala Val Gln Arg Gly Arg Met Pro Pro Thr Gln Pro Thr 
145                 150                 155                 160 


His Gly Gln Phe Ala Leu Thr Asn Gly Asp Pro Leu Asn Cys His Ser 
                165                 170                 175     


Tyr Leu Ser Gly Tyr Ile Ser Leu Leu Leu Arg Ala Glu Pro Tyr Pro 
            180                 185                 190         


Thr Ser Arg Phe Gly Ser Gln Cys Met Gln Pro Asn Asn Ile Met Gly 
        195                 200                 205             


Ile Glu Asn Ile Cys Glu Leu Ala Ala Arg Met Leu Phe Ser Ala Val 
    210                 215                 220                 


Glu Trp Ala Arg Asn Ile Pro Phe Phe Pro Asp Leu Gln Ile Thr Asp 
225                 230                 235                 240 


Gln Val Ala Leu Leu Arg Leu Thr Trp Ser Glu Leu Phe Val Leu Asn 
                245                 250                 255     


Ala Ala Gln Cys Ser Met Pro Leu His Val Ala Pro Leu Leu Ala Ala 
            260                 265                 270         


Ala Gly Leu His Ala Ser Pro Met Ser Ala Asp Arg Val Val Ala Phe 
        275                 280                 285             


Met Asp His Ile Arg Ile Phe Gln Glu Gln Val Glu Lys Leu Lys Ala 
    290                 295                 300                 


Leu His Val Asp Ser Ala Glu Tyr Ser Cys Leu Lys Ala Ile Val Leu 
305                 310                 315                 320 


Phe Thr Ser Asp Ala Cys Gly Leu Ser Asp Val Ala His Val Glu Ser 
                325                 330                 335     


Leu Gln Glu Lys Ser Gln Cys Ala Leu Glu Glu Tyr Val Arg Ser Gln 
            340                 345                 350         


Tyr Pro Asn Gln Pro Thr Arg Phe Gly Lys Leu Leu Leu Arg Leu Pro 
        355                 360                 365             


Ser Leu Arg Thr Val Ser Ser Ser Val Ile Glu Gln Leu Phe Phe Val 
    370                 375                 380                 


Arg Leu Val Gly Lys Thr Pro Ile Glu Thr Leu Ile Arg Asp Met Leu 
385                 390                 395                 400 


Leu Ser Gly Ser Ser Phe Asn Trp Pro Tyr Met Ala Ile Gln 
                405                 410                 


<210>  2
<211>  423
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Ala Met Val Val Ser Ser Trp Arg Asp Pro Gln Asp Asp Val Ala 
1               5                   10                  15      


Gly Gly Asn Pro Gly Gly Pro Asn Pro Ala Ala Gln Ala Ala Arg Gly 
            20                  25                  30          


Gly Gly Gly Gly Ala Gly Glu Gln Gln Gln Gln Ala Gly Ser Gly Ala 
        35                  40                  45              


Pro His Thr Pro Gln Thr Pro Gly Gln Pro Gly Ala Pro Ala Thr Pro 
    50                  55                  60                  


Gly Thr Ala Gly Asp Lys Gly Gln Gly Pro Pro Gly Ser Gly Gln Ser 
65                  70                  75                  80  


Gln Gln His Ile Glu Cys Val Val Cys Gly Asp Lys Ser Ser Gly Lys 
                85                  90                  95      


His Tyr Gly Gln Phe Thr Cys Glu Gly Cys Lys Ser Phe Phe Lys Arg 
            100                 105                 110         


Ser Val Arg Arg Asn Leu Thr Tyr Thr Cys Arg Ala Asn Arg Asn Cys 
        115                 120                 125             


Pro Ile Asp Gln His His Arg Asn Gln Cys Gln Tyr Cys Arg Leu Lys 
    130                 135                 140                 


Lys Cys Leu Lys Val Gly Met Arg Arg Glu Ala Val Gln Arg Gly Arg 
145                 150                 155                 160 


Met Pro Pro Thr Gln Pro Asn Pro Gly Gln Tyr Ala Leu Thr Asn Gly 
                165                 170                 175     


Asp Pro Leu Asn Gly His Cys Tyr Leu Ser Gly Tyr Ile Ser Leu Leu 
            180                 185                 190         


Leu Arg Ala Glu Pro Tyr Pro Thr Ser Arg Tyr Gly Ser Gln Cys Met 
        195                 200                 205             


Gln Pro Asn Asn Ile Met Gly Ile Glu Asn Ile Cys Glu Leu Ala Ala 
    210                 215                 220                 


Arg Leu Leu Phe Ser Ala Val Glu Trp Ala Arg Asn Ile Pro Phe Phe 
225                 230                 235                 240 


Pro Asp Leu Gln Ile Thr Asp Gln Val Ser Leu Leu Arg Leu Thr Trp 
                245                 250                 255     


Ser Glu Leu Phe Val Leu Asn Ala Ala Gln Cys Ser Met Pro Leu His 
            260                 265                 270         


Val Ala Pro Leu Leu Ala Ala Ala Gly Leu His Ala Ser Pro Met Ser 
        275                 280                 285             


Ala Asp Arg Val Val Ala Phe Met Asp His Ile Arg Ile Phe Gln Glu 
    290                 295                 300                 


Gln Val Glu Lys Leu Lys Ala Leu His Val Asp Ser Ala Glu Tyr Ser 
305                 310                 315                 320 


Cys Leu Lys Ala Ile Val Leu Phe Thr Ser Asp Ala Cys Gly Leu Ser 
                325                 330                 335     


Asp Ala Ala His Ile Glu Ser Leu Gln Glu Lys Ser Gln Cys Ala Leu 
            340                 345                 350         


Glu Glu Tyr Val Arg Ser Gln Tyr Pro Asn Gln Pro Ser Arg Phe Gly 
        355                 360                 365             


Lys Leu Leu Leu Arg Leu Pro Ser Leu Arg Thr Val Ser Ser Ser Val 
    370                 375                 380                 


Ile Glu Gln Leu Phe Phe Val Arg Leu Val Gly Lys Thr Pro Ile Glu 
385                 390                 395                 400 


Thr Leu Ile Arg Asp Met Leu Leu Ser Gly Ser Ser Phe Asn Trp Pro 
                405                 410                 415     


Tyr Met Ser Ile Gln Cys Ser 
            420             


<210>  3
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  3
ggacgcagcc cccatagat                                                    19


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  4
aggaaattaa gcaacaaacc ag                                                22


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  5

Ser Gln Ala Ser Gln Ala Pro Pro Val Pro Gly Pro Pro Pro Gly 
1               5                   10                  15  


